A carregar...
Pathogen inactivation and removal methods for plasma‐derived clotting factor concentrates
Pathogen safety is crucial for plasma‐derived clotting factor concentrates used in the treatment of bleeding disorders. Plasma, the starting material for these products, is collected by plasmapheresis (source plasma) or derived from whole blood donations (recovered plasma). The primary measures rega...
Na minha lista:
| Publicado no: | Transfusion |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7169823/ https://ncbi.nlm.nih.gov/pubmed/24117799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.12423 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|